Genome Accessibility and Modification Group
Another group just started to work on the CABMM Research Platform: Andrew Seeber and Michael Hauer aim to improve CRISP-Cas9 efficiency for gene editing in human cells. Embedded with both the DMMD (Altmeyer Group) and the CABMM, the Genome Accessibility and Modification Group is another example of successful collaborations within our network. For more information please visit the CABMM Research Platform.
More news
- ICO-Allergan Advanced Research Fellowship
- Elections CABMM Steering Committee
- The PowerList 2018
- Considerable increase on the CABMM Research Platform!
- ShanghaiRanking's Global Ranking of Academic Subjects 2017
- Prevalence of Keratokonus much higher than previously reported
- Switzerland`s first Down Syndrome eye health consultation
- Intercontinental collaboration
- Ambizione Grant
- Troutman Award for Dr. Sabine Kling
- Another group uses the CABMM Research Platform
- Great success for Prof. Farhad Hafezi
- Renewed approval of the CABMM!
- Updated member section online!
- New research group on the CABMM Research Platform
- New CABMM Steering Committee member
- AneuX project - Towards identifying imaging biomarkers for cerebral aneurysms
- CABMM Report 2012/2013 now available for download !
- GLP Compliance at the CABMM
- Projects Magazine Article
- New research field applicable for CABMM Start-up Grants
- Dr. André N. Tiaden receives the SBMS President Award 2013
- Research Media Ltd Article
- Dr. André N. Tiaden receives funding from the UZH Forschungskredit
- 2nd CABMM Symposium
- Dr. Peter Richards receives SNF Funding
- Histology for and with researchers
- First CABMM Scientific Advisory Board Meeting
- CABMM receives grant for funding research projects
- Dr. Peter Richards new scientific director of the CABMM
- Dr. Silke Mark joins CABMM
- Synthes is supporting the CABMM
- CABMM now in operation